I think some aspies have taken as low as 1 mg. Yeah from what I read about it I do not
blame you for not wanting to take that class of medication. Seems to have more negatives than postives. Maybe you should start a thread asking for everyone on WP to
comment on their history with Risperidone(Risperdal, etc). My guess there will not be many people who have been helped by it. Show it to your family. I would tell your family your not aginst the idea of medication but that risperidone is not a medication that is helping you. I think part of your problem is your parents are dead set on you taking a highly problematic medication. They must have blind faith in some doctor and not what your telling them about the side effects.
This "study" said it was usefull for aspergers but it goes on to say it was not even placebo controlled !(junk science).
1: J Clin Psychiatry. 2005 Dec;66(12):1592-7.
Links
Open-label risperidone for Asperger's disorder: negative symptom spectrum response.
Rausch JL, Sirota EL, Londino DL, Johnson ME, Carr BM, Bhatia R, Miller S.
Department of Psychiatry and Health Behavior, Medical College of Georgia, 1515 Pope Avenue, Augustam GA 30912, USA.
jeffreyr@mail.mcg.eduOBJECTIVE: Asperger's disorder consists of negative symptoms similar to those seen in schizophrenia, autism, schizoid personality disorder, and schizotypal personality disorder. We investigated whether risperidone, which is effective in treating the negative symptoms of schizophrenia, would improve such symptoms observed in Asperger's disorder in a prospective, open-label trial. METHOD: Thirteen male patients aged 6 to 18 years who were diagnosed with Asperger's disorder by DSM-IV criteria were enrolled in a 12-week, prospective, open-label pilot study from March 13, 2002 to August 11, 2003. All subjects were started on risperidone 0.25 mg twice per day. Doses were increased based on clinical indication and tolerability. The primary efficacy variable was the Scale for the Assessment of Negative Symptoms (SANS). Each subject's baseline score served as his control. Secondary efficacy measures included the Positive and Negative Syndrome Scale, Brief Psychiatric Rating Scale, Montgomery-Asberg Depression Rating Scale, Global Assessment Scale, and a modified Asperger Syndrome Diagnostic Scale. RESULTS: We found a statistically significant improvement from baseline for last-observation-carried-forward (LOCF) analyses as well as for analyses of 12-week completers (N = 9) in our primary outcome measure, SANS scores (F = 13.41, p < .0001 for 12-week completers; F = 9.64, p < .0001 for LOCF). We also found statistically significant improvement in all secondary efficacy measurements (F values range, 8.41 to 15.73, p values range, < .0001 to < .005 for 12-week completers; F values range, 6.53 to 7.75, all p < .0001 for LOCF). CONCLUSIONS: Subjects' symptoms significantly improved after risperidone.
The open-label nature of this small pilot study suggests caution in interpreting these data, but the results suggest that placebo-controlled trials should follow.PMID: 16401163 [PubMed - indexed for MEDLINE]
This is the newest information I could find on the science. This small non-placebo controlled study of 13 males. You might want to talk to a lawyer about this(without your families knowledge!)
You might be entitled to damages from your family, doctors and pharametical companies.
06 Apr 2007, 3:28 pm
